Unique ID issued by UMIN | UMIN000017944 |
---|---|
Receipt number | R000020797 |
Scientific Title | Phase I exploratory clinical research on the use of High-Density Mesenchymal Stem Cell Scaffold-Free Autologous Constructs derived from adipose tissue for the donor site of mosaic plasty plugs for osteochondral regeneration therapy |
Date of disclosure of the study information | 2015/07/01 |
Last modified on | 2019/07/07 12:12:54 |
Phase I exploratory clinical research on the use of High-Density Mesenchymal Stem Cell Scaffold-Free Autologous Constructs derived from adipose tissue for the donor site of mosaic plasty plugs for osteochondral regeneration therapy
Clinical research on osteochondral tissue regeneration using adipose derived mesenchymal stem cell constructs
Phase I exploratory clinical research on the use of High-Density Mesenchymal Stem Cell Scaffold-Free Autologous Constructs derived from adipose tissue for the donor site of mosaic plasty plugs for osteochondral regeneration therapy
Clinical research on osteochondral tissue regeneration using adipose derived mesenchymal stem cell constructs
Japan |
Patients with cartilage injury, osteochondritis dissecans, disengaged osteochondral bone fracture, or idiopathic osteonecrosis of the knee joint
Orthopedics |
Others
NO
To evaluate the safety and osteochondral regeneration using implanted "High-density Mesenchymal Scaffold-Free Stem Cell Autologous Construct (HDMAC)" derived from adipose tissue for donor site of mosaic plasty plugs
Safety
Exploratory
Phase I,II
Incidence rate of the adverse events and side effects that occur after grafting
Evaluation of osteochondral regeneration in the HDMAC plug implanted area compared with the non implanted area by MRI and arthroscopy with ICRS scoring
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
HDMAC plug implanted
20 | years-old | <= |
60 | years-old | >= |
Male and Female
Subjects must meet all of the eligibility listed below to be enrolled in the trial.
1) Age : >= 20 and <= 60 years old at the time of obtaining informed consent
2) Patients with cartilage injury, osteochondritis dissecans, disengaged osteochondral bone fracture or idiopathic osteonecrosis of the knee joint diagnosed by MRI
3) Patients have a lesion area (shoulder, knee, elbow, joint) larger than 100mm2
4) Patients with normal hematopoietic function (screening test results showing blood composition to be within the following ranges; white blood cell count (3,000-10,000/uL), platelet count (140,000-440,000/uL), hemoglobin (10.0-18.0g/dL).
5) Patients without serious problems on kidney (CRE;0.65-1.07mg/dL for male, 0.46-0.79 mg/dL for female) and liver (ALT;6-90U/L, AST;13-90U/L, total bilirubin;0.3-3.6mg/dL), uncontrolled heart dysfunctions including arrhythmia and angina pectoris, uncontrolled diabetes or high blood pressure
6) Suitable as a subject as results of screening test conducted after obtaining informed consent
7) Participate this trial based on subject's own free will and give informed consent in written form
Subjects that meet the following criteria will be excluded from the trial.
1) Has past undergone osteochondral surgery
2) Has past suppurative arthritis in the affected area
3) Has past rheumatism, gout or other arthritis
4) Has present or past contagious disease within 3 months of registering for the trial
5) Positive for syphilis , HBs antigens, HCV, HIV parvovirus or HTLV antigens in the screening test results
6) Was drawn 200ml of whole blood within one month (or 200ml of blood components was drawn within two weeks) of registering
7) Is currently taking antithrombotic or anticoagulant drugs
8) APTT over 41 seconds and PT over 13.5 seconds in the screening test results
9) Is currently undergoing treatment for a malignant tumor or underwent treatment for a malignant tumor (excluding intraepithelial neoplasia) within the last 5 years
10) Has any congenital metabolism or bone disorders
11) Has past history of drug or alcohol abuse
12) Is taking steroids like prednisolone systemically 5mg/day or is taking any immune suppressant drugs
13) Participate other clinical research within 3 months before registration
14) Has a history of drug hypersensitivity reactions (antibacterial agents using cultivated cells such as penicillin etc)
15) Has hypersensitivity for animals (especially for bovine)
16) Has a history of anaphylaxis
17) Pregnant, capable of pregnancy and lactating women
18) Unsuitable for this trial judged by PI or SI
5
1st name | Yasuharu |
Middle name | |
Last name | Nakashima |
Kyushu University Hospital
Department of Orthopedic Surgery
812-8582
3-1-1 Maidashi, Higashi-Ku, Fukuoka
092-642-5488
yasunaka@ortho.med.kyushu-u.ac.jp
1st name | Yukio |
Middle name | |
Last name | Akasaki |
Kyushu University Hospital
Department of Orthopedic Surgery
812-8582
3-1-1 Maidashi, Higashi-Ku, Fukuoka
092-642-5488
akasaki@ortho.med.kyushu-u.ac.jp
Kyushu University Hospital Department of Orthopedic Surgery
AMED
Japanese Governmental office
Center for Clinical and Translational Research
3-1-1 Maidashi, Higashi-Ku, Fukuoka
092-642-5082
byshasiwatas@jimu.kyushu-u.ac.jp
NO
九州大学病院
2015 | Year | 07 | Month | 01 | Day |
Unpublished
5
No longer recruiting
2015 | Year | 06 | Month | 12 | Day |
2015 | Year | 07 | Month | 09 | Day |
2015 | Year | 10 | Month | 01 | Day |
2020 | Year | 03 | Month | 31 | Day |
2015 | Year | 06 | Month | 17 | Day |
2019 | Year | 07 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020797
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |